Smart Walk App for Physical Activity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a smartphone app designed to increase physical activity and reduce the risk of heart disease and type 2 diabetes in African American women. Participants will either use the Smart Walk app, which provides a culturally tailored exercise program, or receive a Fitbit activity monitor for comparison. Ideal candidates are African American women who are not very active and have a BMI over 30. Participants should own a smartphone capable of downloading apps and receiving texts. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to important health advancements.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the Smart Walk app, a smartphone program designed for various cultures, is generally safe for users. The app encourages increased activity, and past studies have not identified any serious issues from its use. Although minor injuries can occur with exercise programs, no major safety concerns have been reported for the Smart Walk app. This indicates that most people use the app without problems.12345
Why are researchers excited about this trial?
Researchers are excited about the Smart Walk app because it offers a culturally tailored approach to boosting physical activity, a unique feature not commonly seen in standard options like gym memberships or generic fitness apps. This tailored intervention is delivered conveniently via smartphone, making it accessible and easy to integrate into daily life. Additionally, the Smart Walk app's personalization aspect addresses the diverse needs of participants, potentially leading to higher engagement and better outcomes compared to traditional fitness trackers like the Fitbit Inspire 3, which provides general activity monitoring without cultural customization.
What evidence suggests that this trial's treatments could be effective for increasing physical activity and reducing risk for heart disease and type 2 diabetes?
This trial will compare the Smart Walk app with a Fitbit Inspire 3 activity monitor. Research has shown that the Smart Walk app helps African American women become more active and lower their risk of heart disease and type 2 diabetes. In a previous study, women using Smart Walk were more active over 8 months. The app is specially designed to meet the needs and preferences of its users, which may enhance its effectiveness. It operates on the principle that people can change their habits by engaging with the app. Early results suggest that this personalized approach can lead to healthier lifestyle choices and possibly reduce health risks.13467
Are You a Good Fit for This Trial?
This trial is for African American women who are looking to increase their physical activity to reduce the risk of heart disease and type 2 diabetes. The details on specific eligibility criteria have not been provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Smart Walk intervention or a Fitbit-only comparison for an active 4-month intervention period
Follow-up
Participants are monitored for safety and effectiveness after treatment with minimal contact
What Are the Treatments Tested in This Trial?
Interventions
- Smart Walk
Smart Walk is already approved in United States for the following indications:
- Increasing physical activity
- Reducing risk for heart disease and type 2 diabetes among African American women
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arizona State University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator